Administering an abbreviated global cognitive test, such as the Montreal Cognitive Assessment (MoCA), is necessary for the recommended first‐level diagnostic criteria for mild cognitive impairment (MCI) in Parkinson's disease (PD).… Click to show full abstract
Administering an abbreviated global cognitive test, such as the Montreal Cognitive Assessment (MoCA), is necessary for the recommended first‐level diagnostic criteria for mild cognitive impairment (MCI) in Parkinson's disease (PD). Level II requires administering cognitive functioning neuropsychological tests. The MoCA's suitability for identifying PD‐MCI is questionable and, despite the importance of cognitive deficits reflected through daily functioning in identifying PD‐MCI, knowledge about it is scarce.
               
Click one of the above tabs to view related content.